An Integral Perspective On Depression
An Integral Perspective On Depression
An Integral Perspective On Depression
1-1-2003
Part of the Philosophy Commons, Psychology Commons, and the Religion Commons
Recommended Citation
Teodorescu, D. S. (2003). Teodorescu, D. S. (2003). An integral perspective on depression. International
Journal of Transpersonal Studies, 22(1), 100–119.. International Journal of Transpersonal Studies, 22 (1).
http://dx.doi.org/10.24972/ijts.2003.22.1.100
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
This Special Topic Article is brought to you for free and open access by International Journal of Transpersonal
Studies. It has been accepted for inclusion in International Journal of Transpersonal Studies by an authorized
administrator. For more information, please contact the editors.
An Integral Perspective on Depression
Dinu Stefan Teodorescu
Norwegian Transpersonal Association
The integral approach to therapy proposes to accommodate all the etiological factors of
unipolar depression in its theory, as well as to make use of all existing therapies, both phar-
macological and psychological, in the treatment of unipolar depression. Integral Therapy is
compared to cognitive therapy to find evidence for its superiority over the cognitive
approach. It appears that the cognitive therapy is more cost-effective than Integral Therapy
as an individual approach in the treatment of depression, but that the integral perspective
accounts better for etiological factors.
Introduction are not really double-blind, since during the trials the
subjects come to realize whether they have placebo or
D
epression is the most widespread mental dis- not. Because of the pressure from medical insurance
order, and in 1999 as many as 1 in 20 companies, psychotherapies have been urged to devel-
Americans were severely depressed (Satcher, op short-duration therapies that can be quantified,
1999). Every year, about 6 million people suffer from and today the field has developed a new approach, the
depression in the U.S., with a cost of more than 16 bil- so-called evidence-validated therapies (EVT), propos-
lion dollars; 60% of suicides have their roots in major ing that only those therapies that have a research-based
depression, and 15% of patients admitted for depres- evidence should be considered. However, the benefits
sion to a psychiatric hospital kill themselves of EVT over the other therapies have been questioned
(Nierenberg, 2001). The recovery rate from major (Lampropoulos, 2000; Henry, 1998; Garfield, 1996).
depressive disorder (MDD) is as follows: 50% of those For the time being, there are only two therapies
who had a major depressive episode and recovered will that are recommended by the American Psychiatric
never experience a new episode; while 40% will have Association (APA) for the treatment of MDD based
MDD recurrence in the future, and 10% will never on research evidence: namely, cognitive therapy (CT)
recover and will experience a chronic depression and interpersonal therapy (IPT) (American Psychiatric
(Passer & Smith, 2001). Association, 1993). The question which remains is
Depression is perhaps the most researched mental what shall be the fate of the 200 or more existing psy-
disorder. Street et al. (1999) list more than 27 theories chotherapies (Bohart et al., 1998; Chambless et al.,
of depression and 99 factors that contribute to its 1998) that may work as well as CT and IPT, but for
onset and maintenance. Of the 27 theories, none is the time being don’t seem to have the “credentials”
able to accommodate all these factors. The classical from research. Some of them, such as psychoanalysis
ones have concentrated only on some of them, often and some humanistic psychotherapies, may prove
getting in conflict with other theories that emphasised impossible to quantify using a research setting, and in
other factors, and thus giving rise to an unfortunate the end they may prove “too long and expensive” for
competition for the “truth.” the health insurance companies.
Today we see in the U.S. a real battle between phar- Given this growing problem for today’s psy-
macotherapy and psychotherapy in claiming full rights chotherapies, it is indeed “unreasonable” to propose a
in the treatment of MDD. The psychotherapy quarter new therapy, which may prove even longer in achiev-
seems to be losing ground because of the problem of ing results and even more difficult to be tested in an
funding research, while the pharmacology quarter is experimental setting. And it is a problem for the pres-
obviously supported by large grants from the pharma- ent paper, meant to introduce a new form of therapy
ceutical industry. The double-blind pharmacology for MDD, Integral Therapy (IT).
studies on MDD have all been criticised, because they Psychotherapy integration has long been an ideal
Table 1. Structures, levels, memes, worldviews, pathologies and therapies according to Wilber